Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 545441 - 545460 out of 553697 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EH02) neratinib (adm: O) | NERLYNX 40MG TAB | 180 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PumaBiotechnology,Inc. |
| USA | (L01EH02) neratinib (adm: O) | NERLYNX 40MG TAB | 133 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PumaBiotechnology,Inc. |
| USA | (L01EH02) neratinib (adm: O) | NERLYNX 40MG TAB | 133 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PumaBiotechnology,Inc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 150MG TABLET | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | PfizerInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 150MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | PfizerInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 150MG TABLET | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | PfizerInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 150MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | PfizerInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 50MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | PfizerInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 50MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | PfizerInc. |
| USA | (L01EH04) zongertinib | HERNEXEOS 60MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L01EJ02) fedratinib (adm: O) | INREBIC 100MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Primary Myelofibrosis | Bristol-MyersSquibbCompany |
| USA | (L01EJ02) fedratinib (adm: O) | INREBIC 100MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Primary Myelofibrosis | Bristol-MyersSquibbCompany |
| USA | (L01EJ03) pacritinib | VONJO 100MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Sobi,Inc. |
| USA | (L01EJ03) pacritinib | VONJO 100MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Sobi,Inc. |
| USA | (L01EJ04) momelotinib (adm: O) | OJJAARA 100MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Splenomegaly;Myeloproliferative Disorders | GlaxoSmithKline |
| USA | (L01EJ04) momelotinib (adm: O) | OJJAARA 100MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Splenomegaly;Myeloproliferative Disorders | GlaxoSmithKline |
| USA | (L01EJ04) momelotinib (adm: O) | OJJAARA 150MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Splenomegaly;Myeloproliferative Disorders | GlaxoSmithKline |
| USA | (L01EJ04) momelotinib (adm: O) | OJJAARA 150MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Splenomegaly;Myeloproliferative Disorders | GlaxoSmithKline |
| USA | (L01EJ04) momelotinib (adm: O) | OJJAARA 200MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Splenomegaly;Myeloproliferative Disorders | GlaxoSmithKline |
| USA | (L01EJ04) momelotinib (adm: O) | OJJAARA 200MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Splenomegaly;Myeloproliferative Disorders | GlaxoSmithKline |
Pages
